Pharmacology

Pharmacology is the study of how chemical substances interact with living systems. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities.

Pharmacology

Pharmacology is the study of the action of drugs on a biologic system. It incorporates components of medicine and biology, and how they interact with each other.

Importance of Allostery in Pharmacology

What is Psychopharmacology?

Infliximab Pharmacology

What is Pharmacoepidemiology?

Pharmacology of CAR-T Cells

Opioid Pharmacology

Pharmacokinetics

Metabolomics in Pharmacology

What is Quantitative Systems Pharmacology (QSP) Modeling?

Drug Metabolism

Importance of Pharmacology in Dentistry

See more featured articles »

What is Toxicology?

Synthetic and Patented Cannabinoids

DNA and Technology

Hormone Pharmacology

Psychopharmacology and Neuropsychopharmacology Research

What is Pharmacodynamics?

Nicotine Pharmacology

Geriatric Pharmacology: Medication Management for an Aging Population

Calcitonin Pharmacology

Warfarin Pharmacology

Halicin: The AI-Discovered Antibiotic That Fights Superbugs

How Can Biochemistry Practices be made Virtual?

Valproic Acid Pharmacology

Pharmacology of Paracetamol

Carboplatin Pharmacology

Drug Distribution

Olanzapine Pharmacology

Bottom-Up Approach Overview

Morphine Pharmacology

Drug Excretion / Elimination

Pharmacist Career

What is Neuropharmacology?

Celebrex (Celecoxib) Pharmacology

What Are Adaptogens-and Do They Actually Work?

Pharmacology of Cannabinoid Receptors

What is a Dose-Response Curve?

Haloperidol Pharmacology

What is in Silico?

What is Efficacy?

What is Drug Absorption?

How Nasal Spray Use and Overuse Affects the Nose

Caffeine Pharmacology

Latest Pharmacology News and Research

Alterations in liver metabolism experienced by individuals with Down syndrome

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered compelling evidence that individuals with Down syndrome experience significant alterations in liver metabolism, including elevated levels of bile acids in the bloodstream and other biomarkers of liver dysfunction.

22 Jan 2026

Understanding tumor growth patterns helps guide treatment after lung cancer

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

21 Jan 2026

GLP-1 weight-loss drugs show early promise for treating addiction

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential treatments for substance use disorders. Findings show consistent reductions in drug- and alcohol-seeking behaviors in animal models, while human evidence remains limited, heterogeneous, and preliminary.

21 Jan 2026

Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis

Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program to develop a comprehensive and innovative approach to diagnosing lymphatic disease.

20 Jan 2026

New review examines the growing global use of melatonin among pediatric populations

Sleep problems are increasingly common among children and adolescents, affecting emotional regulation, cognitive development, and healthy conditions.

16 Jan 2026

CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct.

15 Jan 2026

Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer.

13 Jan 2026

Brain immune cells drive persistent negative emotions after repeated binge drinking

New research has identified that neuroinflammation driven by microglia (immune cells in the brain) is a primary underlying driver of prolonged negative feelings caused by repeated, sustained binge drinking (binge exposure).

12 Jan 2026

Why adherence determines weight loss success with semaglutide

Researchers examine how the effectiveness of weight-loss medications may depend on the patient adherence.

12 Jan 2026

Personalized cancer therapy significantly enhances treatment success

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based on the unique DNA of a patient's tumor.

12 Jan 2026

Perfectionism and competitive sports practice associated with risk of exercise addiction

Physical exercise is one of the main recommendations for maintaining good health. However, when practiced compulsively and without control, it can become a problem: exercise addiction.

12 Jan 2026

Scientists identify a molecular switch that controls water flow in the gut

Although constipation and diarrhea may seem like opposite problems, they both hinge on the same underlying issue: how much fluid moves into the gut. These common issues affect millions of people in the U.S. each year, yet scientists have not fully understood what regulates intestinal fluid balance.

9 Jan 2026

Individualized drug combinations improve cancer treatment outcomes

8 Jan 2026

Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatment

About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP).

8 Jan 2026

Recent advances in CAR-NK cell therapy could revolutionze cancer treatment

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, manufacturing complexity, and limited effectiveness against solid tumors.

8 Jan 2026

UC Davis team creates new class of serotonin-effecting drugs

UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - into molecules that are similar in structure to psychedelics and mimic their interaction with the brain.

8 Jan 2026

Reprogramming immunity to protect beta cells in type 1 diabetes

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the leading global T1D research and advocacy organization, Leonardo Ferreira, Ph.D., assistant professor of Pharmacology and Immunology, and his collaborators at partnering institutions will explore a new approach to treating – and potentially curing – the disease.

7 Jan 2026

Microglia help protect the spinal cord from age-related damage

Researchers at Karolinska Institutet have discovered that the nervous system's own immune cells help protect the spinal cord from age-related damage.

7 Jan 2026

Study reveals bioactive compounds driving Borage's diverse therapeutic benefits

For centuries, Borago officinalis - commonly known as Borage or the Starflower - has been a staple of traditional medicine.

6 Jan 2026

Charting brain cell epigenomics to reveal origins of psychiatric disorders

In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Maria Margarita Behrens recounts an extraordinary scientific journey that wound through four countries and multiple disciplines before arriving at fundamental questions about how the brain develops and what goes wrong in psychiatric disorders.

6 Jan 2026